Moringa Supplementation for Improved Milk Output
Launched by UNIVERSITY OF KENTUCKY · Apr 11, 2022
Trial Information
Current as of May 03, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- • Mom
- YES:
- • willing to breastfeed or pump for one week
- • willing to complete study activities (at minimum measure 24 hour pumped volume at start and end of capsules, take capsules daily, and answer questions)
- • has access to breastpump (in hospital and/or home)
- • English speaking
- • 18 years or older
- • Gave birth between 2-6 weeks prior to study start
- NO:
- • taking metoclopramide (trade name Reglan) currently or within 2 weeks of enrollment
- • taking moringa regularly or within 2 weeks of enrollment
- • breast surgery (amplification, reduction, or other)
- • breast condition: Insufficient Glandular tissue
- • unprescribed or street drug use at any point in pregnancy, or enrolled in rehab program or receiving addiction therapy
- • refuses to take 4 capsules twice daily within 2 days of study start
- • wishes to withdraw within 2 days of study start
- • Infant
- YES:
- • 28-36 and 7 weeks gestation (ie 37 weeks is too old)
- • 2-6 weeks old
- • singleton birth
- NO:
- • · any condition where breastmilk is clinically contraindicated
About University Of Kentucky
The University of Kentucky is a leading academic institution dedicated to advancing healthcare through innovative research and clinical trials. With a strong emphasis on interdisciplinary collaboration, the university leverages its extensive resources and expertise to conduct rigorous clinical studies aimed at improving patient outcomes and addressing pressing medical challenges. The institution is committed to ethical research practices and strives to enhance community health by translating scientific discoveries into effective treatments and interventions. Through its Clinical Trials Office, the University of Kentucky fosters a supportive environment for researchers and participants alike, ensuring a comprehensive approach to clinical research that meets the highest standards of excellence.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Lexington, Kentucky, United States
Lexington, Kentucky, United States
Patients applied
Trial Officials
Suzanna Attia, MD
Principal Investigator
University of Kentucky
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials